Chemomab Therapeutics Ltd... (CMMB)
NASDAQ: CMMB
· Real-Time Price · USD
0.94
0.04 (4.76%)
At close: Aug 15, 2025, 3:58 PM
0.95
1.58%
After-hours: Aug 15, 2025, 07:26 PM EDT
Chemomab Therapeutics Balance Sheet Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Cash & Equivalents | 6.07M | 6.6M | 5.04M | 4.74M | 9.37M | 9.23M | 10.38M | 20.77M | 13.52M | 10.74M | 9.88M | 13.83M | 14.69M | 37.74M | 45.4M | 58.18M |
Short-Term Investments | 8.2M | 12.78M | 7.69M | 11.21M | 10.49M | 12.22M | 16.21M | 11.94M | 26.37M | 35.73M | 41.84M | 43.58M | 46.48M | 26.52M | 21.52M | 23K |
Long-Term Investments | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 77K | 77K | 85K | 55K | 53K | 53K | 4K |
Other Long-Term Assets | 378.38K | 428K | 472K | 516K | 559K | 602.99K | 646K | 690K | 733K | 776K | 821K | 864K | 908K | 952K | 995K | 51K |
Receivables | 263K | 439K | 654K | 885K | n/a | n/a | n/a | 995K | 459K | 2.26M | 3.11M | 1.93M | 179K | 1.57M | 1.92M | 320K |
Inventory | n/a | n/a | n/a | -885K | -1.04M | -993 | 72.88K | -12.94M | n/a | -37.98M | -44.95M | -45.51M | -1.35M | -28.1M | -23.44M | n/a |
Other Current Assets | 76K | 75K | 2.00 | 6.00 | 365K | n/a | 1.12K | 77K | 77K | n/a | n/a | n/a | n/a | n/a | n/a | 1M |
Total Current Assets | 16.04M | 19.89M | 13.46M | 16.84M | 20.9M | 22.37M | 27.7M | 33.78M | 41.74M | 48.73M | 54.83M | 59.34M | 62.69M | 65.84M | 68.83M | 59.52M |
Property-Plant & Equipment | 539K | 577K | 617K | 656K | 695K | 448.99K | 498K | 545K | 594K | 641K | 650K | 667K | 702K | 593K | 635K | 545K |
Goodwill & Intangibles | 6.62K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Assets | 924K | 1M | 1.09M | 1.17M | 1.25M | 1.05M | 1.14M | 1.24M | 1.33M | 1.49M | 1.55M | 1.62M | 1.67M | 1.6M | 1.68M | 600K |
Total Assets | 16.96M | 20.9M | 14.54M | 18.01M | 22.15M | 23.42M | 28.85M | 35.01M | 43.06M | 50.22M | 56.38M | 60.96M | 64.35M | 67.44M | 70.52M | 60.12M |
Account Payables | 666K | 386K | 1.11M | 527K | 516K | 730.99K | 2.35M | 2.22M | 1.69M | 1.25M | 1.43M | 1.49M | 1.34M | 481K | 472K | 2.08M |
Deferred Revenue | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Short-Term Debt | n/a | n/a | -2.55M | n/a | n/a | n/a | n/a | 115K | n/a | n/a | 132K | n/a | n/a | 61K | 72K | 69K |
Other Current Liabilities | 874K | 727K | 9.00 | n/a | 3.42M | 3.01M | n/a | 3.05M | n/a | n/a | 1.58M | n/a | n/a | 576K | 905K | 1.89M |
Total Current Liabilities | 3.22M | 4.35M | 4.31M | 4.4M | 4.84M | 5.37M | 6.83M | 7M | 6.75M | 5.48M | 4.39M | 3.52M | 2.65M | 1.63M | 2.16M | 4.63M |
Long-Term Debt | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Other Long-Term Liabilities | n/a | n/a | n/a | n/a | n/a | 0.08 | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Total Long-Term Liabilities | 209K | 230K | 251K | 280K | 316K | 5K | 33K | 62K | 91K | 118K | 148K | 203K | 237K | 298K | 320K | 328K |
Total Liabilities | 3.43M | 4.58M | 4.56M | 4.68M | 5.15M | 5.37M | 6.86M | 7.06M | 6.84M | 5.59M | 4.54M | 3.72M | 2.89M | 1.93M | 2.48M | 4.96M |
Total Debt | 324K | 342K | 360K | 390K | 392K | 110K | 141K | 177K | 214K | 244K | 280K | 319K | 343K | 359K | 392K | 397K |
Common Stock | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Retained Earnings | -102.62M | -99.66M | -96.18M | -92.55M | -88.68M | -84.62M | -80.54M | -72.57M | -63.82M | -55.55M | -47.47M | -41.28M | -36.17M | -31.14M | -28.17M | -25.4M |
Comprehensive Income | 0.00 | n/a | n/a | 0.00 | n/a | -0.00 | -0.00 | 0.00 | -0.00 | -0.00 | n/a | -0.00 | 0.00 | n/a | 0.00 | n/a |
Shareholders Equity | 13.54M | 16.32M | 9.99M | 13.33M | 17M | 18.04M | 21.99M | 27.95M | 36.22M | 44.62M | 51.84M | 57.24M | 61.47M | 65.51M | 68.04M | 55.16M |
Total Investments | 8.2M | 12.78M | 7.69M | 11.21M | 10.49M | 12.22M | 16.21M | 11.94M | 26.37M | 35.73M | 41.84M | 43.58M | 46.48M | 26.52M | 21.52M | 27K |